SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,131,105 | -22.4% | 5,914,252 | 0.0% | 0.09% | -13.0% |
Q4 2022 | $5,322,827 | -85.0% | 5,914,252 | 0.0% | 0.11% | -85.7% |
Q3 2022 | $35,486,000 | +44.9% | 5,914,252 | 0.0% | 0.76% | +15.9% |
Q2 2022 | $24,485,000 | +8.9% | 5,914,252 | 0.0% | 0.65% | +33.3% |
Q1 2022 | $22,474,000 | -15.6% | 5,914,252 | 0.0% | 0.49% | +4.5% |
Q4 2021 | $26,614,000 | -3.4% | 5,914,252 | 0.0% | 0.47% | +22.8% |
Q3 2021 | $27,560,000 | -33.9% | 5,914,252 | 0.0% | 0.38% | -42.9% |
Q2 2021 | $41,695,000 | +19.3% | 5,914,252 | 0.0% | 0.67% | +26.9% |
Q1 2021 | $34,953,000 | +61.9% | 5,914,252 | +26.3% | 0.53% | +74.5% |
Q4 2020 | $21,583,000 | +18.5% | 4,681,858 | 0.0% | 0.30% | -9.3% |
Q3 2020 | $18,212,000 | -86.5% | 4,681,858 | 0.0% | 0.33% | -87.3% |
Q2 2020 | $134,650,000 | +33.6% | 4,681,858 | 0.0% | 2.62% | -17.6% |
Q1 2020 | $100,754,000 | +9.4% | 4,681,858 | 0.0% | 3.18% | +13.9% |
Q4 2019 | $92,139,000 | +31.1% | 4,681,858 | 0.0% | 2.79% | -33.3% |
Q3 2019 | $70,275,000 | – | 4,681,858 | – | 4.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |